Introduction:
The medicinal plant marshmallow Althaea officinalis L. (A. officinalis), is used for the treatment of cough since centuries. Application of medicinal extracts of marshmallow roots shows immediate effects like a protective film on the inflamed mucosa. Because the soothing layer reduce irritation of the mucous system, a faster regeneration is supported by defense mechanisms required to protect the respiratory tract from environmental injury. Macrophages (M ), which belong to a group of multipurpose defensive cells, provide the first line of defense against mucosal invasive pathogens. The present study was performed to investigate, whether the herbal medicinal product has anti-inflammatory or anti-oxidative effects on pro-inflammatorily activated M or after oxidative stress induction. Special attention should be payed to elucidate the effects of A. officinalis on the mechanism of intracellular defense as well as on migratory capacity of the M .
Results: Treatment of PMA-differentiated human THP-1 M with Phytohustil R increased their viability without affecting the cell number. Phytohustil R or root extracts of A. officinalis (REAo) -an active component of Phytohustil R -were able to protect human M against H 2 O 2 -induced cytotoxicity and H 2 O 2 -induced ROS production. Phytohustil R , REAo or diclofenac used as anti-inflammatory reference substance, inhibited the LPS-induced release of tumor necrosis factor-alpha (TNF-α) as well as of IL6 in M . Treatment with Phytohustil R , its excipients or REAo did not impair the mitochondrial membrane potential (MMP). Finally, Phytohustil R and REAo activated the migratory capacity of M .
Conclusion: The present in vitro investigations indicate protective, i.e., anti-oxidative and anti-inflammatory effects of REAo and Phytohustil R , additionally improving the migratory capacity of M . These antiinflammatory effects were similar or even better than diclofenac. Thus, our data support and may explain the positive effect of Phytohustil R observed in patients during the therapy of inflamed buccal mucosal membranes or treatment of cough.
INTRODUCTION
Althaea officinalis L. (Malvaceae), also called marshmallow, is known as a medicinal plant from ancient time for the treatment of the irritation of laryngopharyngeal mucosa and hence associated dry cough. Many compounds have been extracted from A. officinalis, including starch (25-35%), pectins (11%), saccharose (10%), mucilage (5%), flavonoids, caffeic acid, p-coumaric acid, isoquercitrin, coumarins, phytosterols, tannins, etc., as well as many amino acids (Gudej, 1991; Bradley(ed.), 1992) . Root extract of Althaea officinalis (REAo) contains water-miscible polysaccharides (acidic polysaccharides), mostly galacturorhamnans, arabinans, glucans, and arabinogalactans (Capek et al., 1987) . The common oral use of REAo against dry cough caused by pharyngeal and mucosal irritation, is related to the bio-adhesive properties of the polysaccharides to the epithelial mucosa, which protects the cells from mechanical irritations and microbial invasion (Sendker et al., 2017) . However, phytochemical investigations indicating the presence of bioactive low molecular weight compounds, as flavonoid-Osulfoglycosides, and limiting the effects of REAo only to the mucilaginous effects of high molecular weight polysaccharides is not enough to explain the properties of A. officinalis (Sendker et al., 2017) . O-sulfopolysaccharides are involved in the formation and regulation of the extracellular matrix (ECM) in the mucosal tissue (Sendker et al., 2017) . This connection can trigger cell-matrix interactions and subsequent migration, cytokine signaling, as well as leukocyte activation in both, normal and pathological conditions (Korpos et al., 2010) . The migration of M , is greatly influenced by the composition of the local ECM, affecting both, the persistence and directionality of migration in vivo (Wang et al., 2006; Korpos et al., 2010) . Transient recruitment and migration of polymorphonuclear leukocytes (PMNs), followed by M accumulation is the host response to tissue injury or infection, characterized by the local production of inflammatory mediators, such as cytokines (Nathan, 2006) . A special function in the regulation of ECM, especially in wound healing and inflammation, is attributed to hyaluronic acid (Sendker et al., 2017) . It has recently been published that REAo inhibited the enzymatic activity of human hyaluronidase-1 expressed on the cell wall surface of Escherichia coli F470 bacteria and reduced its adhesive capacity on the ECM (Sendker et al., 2017) . High molecular weight (>20 kDa) hydrophilic hyaluronic acid exerts anti-inflammatory effects by impairing the migration of leukocytes and M , induction of cell proliferation and differentiation (Heldin, 2003) . After migration, tissue-resident M ingest bacteria, dead cells and recognize LPS, that stimulates the synthesis and secretion of pro-inflammatory cytokines, such as TNF-α, IL6, IL-1β etc. (Bochsler et al., 1993) . Secretion of cytokines is an important component of host defense, allowing the immune system to detect and respond to small quantities of LPS in the early stages of bacterial infection, but anti-inflammatory agents are necessary to limit the cytokine hypersecretion during the resolution of the inflammation (Adams and Czuprynski, 1990) . Many studies confirm that inflammation and oxidative stress are interdependent and interconnected processes. Inflammatory cells like M release a number of ROS at the site of inflammation triggering oxidative damage and enhancing pro-inflammatory responses (McGarry et al., 2018) . The balance of intracellular ROS is extremely important in maintaining normal physiology and cellular integrity. While the mitochondrial respiratory chain is the major component which cells use to produce intracellular ROS, cells reduce harmful excessive ROS via anti-oxidant enzymes such as catalase, superoxide dismutase, glutathione peroxidase, and glutathione reductase (Tan et al., 2016) . Anti-oxidant properties of REAo have been described. Marshmallow exhibited strong total antioxidant activity, as well as effective reducing power, free radical/superoxide anion radical scavenging, and metal chelating activities (Elmastas et al., 2004) , i.e., such extracts may be involved in the resolution of inflammation via anti-oxidative activity and phagocytosis regulation (Elmastas et al., 2004) .
Phytohustil R an herbal medicinal product containing REAo is commonly used for the treatment of mucous membrane irritations in the mouth and throat and the dry cough associated with this. The aim of this study was to investigate in vitro in human M the beneficial anti-inflammatory and anti-oxidative properties of the well-known product Phytohustil R compared to its major components, the REAo.
MATERIALS AND METHODS

Cell Culture
The in vitro experiments were performed using the THP-1 (human acute monocytic leukemia) cell line (DSMZ GmbH, Braunschweig, Germany), cultured in RPMI complete medium [90% RPMI-1640 (PAA GmbH, Cölbe, Germany), 10% fetal bovine serum (FBS, PAA GmbH); 100 U/ml penicillin; 0.1 mg/ml streptomycin (PAA GmbH)].
Tested Substances
Steigerwald Arzneimittelwerk GmbH (Steigerwald, Darmstadt, Germany) provided STW42-H marshmallow (REAo) as active constituent. REAo was prepared by maceration of the roots of A. officinalis in purified water (dry REAo batch-No. 14-0450; lot 00000816334) with a drug-extract-ratio (DER) of 3-9:1 after drying. 100 g Phytohustil R cough syrup (Bayer AG, Leverkusen, Germany; batch-No. 730041; shelf life 2019/12) contains 35.6 g liquid REAo as active ingredient at a DER 19.5-23.5:1 according to DAC (German Drug Codex) 1999. Steigerwald Arzneimittelwerk GmbH also provided excipients, ethanol, propyl-4-hydroxybenzoate EP, methyl-4-hydroxybenzoate EP, sucrose. The concentration of Phytohustil R was calculated in µg/ml dry extract.
The REAo was previously characterized and published (Sendker et al., 2015 (Sendker et al., , 2017 Fink et al., 2018) . A representative chromatogram of the REAo batch-No. 14-0450 is shown in the Supplementary Figure S1 . Diclofenac sodium salt (Merck/Sigma-Aldrich Chemie GmbH, CAS, 15307-79-6) was used as an anti-inflammatory reference substance.
Measurements of the Viability and Survival of Human M
THP-1 cells (3 × 10 4 ) seeded in 100 µl medium/well in 96well plates (Falcon TM , BD Bioscience, Heidelberg, Germany) were incubated overnight in RPMI complete medium, and differentiated into M by incubation with of 0.1 µg/ml phorbol-12-myristate-13-acetate (PMA, Merck/Sigma-Aldrich Chemie GmbH, Munich, Germany) for 3-5 days; afterward the medium was changed and different concentrations of the REAo, Phytohustil R or its excipients were added. After 48 h treatment viability and cell number were measured as described below.
As a control (=100% viability), we used cells cultured with medium alone (∼ untreated control). Cell viability was assessed using PrestoBlue R reagent (Fisher Scientific GmbH, Schwerte, Germany). PrestoBlue R was directly added to the cells (into the culture medium) at a final concentration of 10% and measured according to the manufacturer's specifications. Results were expressed in % of viability (OD 570nm/600nm of samples × 100/OD 570nm/600nm of untreated control). After the PrestoBlue R reaction, the cells were fixed with 4% PFA/PBS and stained with crystal violet (Merck/Sigma-Aldrich Chemie GmbH) solution (0.04% crystal violet in 4% ethanol [v/v]) and washed; afterward the cells were lysed in a 1% sodium dodecyl sulfate (SDS, Merck/Sigma-Aldrich Chemie GmbH) solution. The crystal violet absorbance was measured at 595 nm (reference 655 nm) to spectrophotometrically determine the total cell number.
Determination of the Protective Effects Against H 2 O 2 -Induced Cytotoxicity
The protective effect of the REAo, Phytohustil R or its excipients against cytotoxicity induced by H 2 O 2 treatment was determined using the PrestoBlue R viability assay (Fisher Scientific GmbH) and crystal violet cell quantification assay as described above. In detail, 3 × 10 4 THP-1 cells were seeded in 100 µl medium/well using 96-well plates (Falcon TM , BD Bioscience) and differentiated with PMA in M , the medium was changed and the M were pre-treated for 48 h with noncytotoxic concentrations of the REAo, Phytohustil R or its excipients. Afterward, the M were treated with or without 5 mM H 2 O 2 (3 h) and quantification of viability and cell number was performed.
Determination of the Mitochondrial Membrane Potential (MMP, m)
Mitochondrial membrane potential was measured in 3 × 10 4 PMA-differentiated M as described above by using 10 µM of the fluorescent mitochondrial dye JC-10 (Biomol GmbH, Hamburg, Germany) in black Lumox multi well plates (Sarstedt AG & Co., Nümbrecht, Germany). After treatment with the REAo, Phytohustil R or its excipients, the cells were incubated (5-15 min) in serum-free medium containing JC-10 dye loading solution (according to the manufacturer's protocol). JC-10 accumulates in mitochondria, selectively generating an orange J-aggregate emission profile (590 nm) in healthy cells. However, upon cell injury, as membrane potential decreases, JC-10 monomers are generated, resulting in a shift to green emission (525 nm 
Determination of Anti-inflammatory Effects
The release of TNF-α or IL6 was determined using enzymelinked immunosorbent assay (ELISA). In detail, 3 × 10 4 PMAdifferentiated M were seeded in 100 µl medium/well using 96-well plates (Falcon TM , BD Bioscience); thereafter, the medium was changed and the M were pre-treated for 48 h with different concentrations of REAo, Phytohustil R or its excipients contained in the corresponding concentrations of Phytohustil R . Afterward, the cells were activated for 3 h with 0.01 µg/ml (TNF-α experiments) or 1.0 µg/ml (IL6 experiments) ultrapure lipopolysaccharide (LPS-EB) from E. coli O111:B4 (Cayla -InvivoGen Europe, Toulouse France) -that is only recognized by toll-like receptor 4 (TLR4). Human TNF-α or IL6 were determined in the culture medium using the assay Duo Set ELISA Development kit (R&D Systems Europe, Ltd., Abingdon, United Kingdom) following the manufacturer's instructions. Afterward the cells were fixed with 4% PFA/PBS and stained with crystal violet and the absorbance was measured as described above. The TNF-α or IL6 OPD absorbance (490 nm and 655 nm reference) was normalized to the crystal violet absorbance.
The results were expressed as % of the released TNF-α or IL6 after stimulation with LPS which was considered as 100% release. Additionally, diclofenac sodium salt was used as antiinflammatory reference substance in our experimental setting (Rupasinghe et al., 2015; Bonaterra et al., 2019) .
Determination of Cellular Reactive Oxygen Species (ROS)
The production of ROS was measured by detecting the fluorescent intensity of the oxidant-sensitive probe 2 - 
Determination of the Migratory Capacity of M
The migratory capacity of M was determined using a scratch assay in 24-well plates; scratches in the cell monolayer at the bottom of the well were made with pipette tips. Then the medium was changed and the cells were exposed to different concentrations (300-500 µg/ml) of REAo, Phytohustil R or its excipients (24 h 
Statistical Analyses
The SigmaPlot 12 software (Systat Software GmbH, Erkrath, Germany) was used to carry out statistical analyses by the unpaired Student's t test or Mann-Whitney U-test. Data was shown as mean + SEM. p < 0.05 was considered as statistically significant.
RESULTS
Effect of Phytohustil R and Root Extract of
A. officinalis on the Viability of M First, we investigated the effect of 48 h treatment on the viability on M using PrestoBlue R cell viability reagent. PrestoBlue R reactivity is based on resazurin, which functions as a cell viability indicator based on mitochondrial enzyme activity (Xu et al., 2015) . In viable cells, resazurin is reduced to resorufin in cellular respiration by accepting electrons from NADPH, FADH, FMNH, NADH and cytochromes (Al-Nasiry et al., 2007) and may be used to measure mitochondrial activity. The treatment of M with 0.01 µg/ml LPS did not affect their viability (Figures 1A-C) . 400 and 500 µg/ml Phytohustil R alone, significantly (p < 0.05) increased the viability by +7.0 to +11.0% in comparison with the negative untreated control (M incubated with medium alone; = 100% viability) ( Figure 1A) . Pre-treatment of M with 400 or 500 µg/ml Phytohustil R and afterward treatment with 0.01 µg/ml LPS significantly (p < 0.05) increased the viability by 10.7% or 13.0% (Figure 1A) . The pre-treatment of M with Phytohustil R 's excipients or REAo with or without LPS did not affect the cell viability (Figures 1B,C) and the cell quantity determined by CV (not shown).
Protective Effects of Phytohustil R or REAo Against H 2 O 2 -Induced Cytotoxicity in M
We investigated the cytotoxic effects of H 2 O 2 and found that 5 mM significantly (p < 0.001) inhibited the viability by 10.4% in comparison with the untreated control (Figures 2A-C) . Pre-treatment (48 h) of M with 100 µg/ml, 250 µg/ml, or 500 µg/ml Phytohustil R led to a significant concentrationdependent inhibition of H 2 O 2 -induced cytotoxicity by 6.7% (p < 0.01), 9.5% (p < 0.001), and 11.4% (p < 0.001) in comparison to 3 h treatment with 5 mM H 2 O 2 (Figure 2A) . Pretreatment of M with excipients only at the concentration of 500 µg/ml, showed a significant (p < 0.05) 6.3% inhibition of H 2 O 2 -induced cytotoxicity (Figure 2B) . Pre-incubation of M with 500 µg/ml REAo significantly (p < 0.001) attenuated the 5 mM H 2 O 2 -mediated cytotoxicity by 10.9% (Figure 2C) . After treatment of M with 5 mM H 2 O 2 we found a significantly (p < 0.01) decreased cell number by 16.4% when compared to the untreated control, considered as 100% of CV absorbance (as 100% cell quantity) (Figures 3A-C) . Pre-treatment with 100 µg/ml, 250 µg/ml or 500 µg/ml Phytohustil R significantly inhibited the H 2 O 2 -mediated decreasing cell number by 19.5% (p < 0.01), 19.7% (p < 0.01), and 12.4% (p < 0.05) ( Figure 3A) . Incubation of M with excipients exhibited no cell number protecting effects against H 2 O 2 inducedcytotoxicity (Figure 3B) . Pre-treatment with REAo also showed no cell number protecting effects compared to H 2 O 2 -treated cells (Figure 3C ).
Effects of Phytohustil R or REAo on the Mitochondrial Membrane Potential (MMP) in M
According to the results observed after quantification of cell viability, we investigated the effects of Phytohustil R , its excipients or REAo on the MMP. We utilized the JC-10 dye, which is useful for determining the MMP by fluorescence microscopy. H 2 O 2 (12.5 mM) is used as a control, which significantly (p < 0.001) increased the MMP depolarization by 76.7% compared to untreated control (∼ 100% MMP integrity) (Figure 4) . Treatment (80, 100, or 200 µg/ml; 48 h) of M with Phytohustil R , its excipients or REAo did not affect the MMP compared to the untreated control (Figure 4) .
Protective Effects of Phytohustil R or REAo Extract Against H 2 O 2 -Induced on ROS Production in M
Reactive oxygen species are generated during mitochondrial oxidative metabolism. When ROS rise above the antioxidant defenses, because of a decrease in the cellular antioxidant capacity or an increase in ROS levels, oxidative stress occurs. Incubation of M with Phytohustil R (100 µg/ml), its excipients or REAo (100 µg/ml) did not affect the ROS level compared to untreated control (Figure 5) . Treatment with H 2 O 2 (12.5 mM) significantly (p < 0.01) increased the ROS production by 96.9% compared to untreated control (Figure 5) . Pre-treatment of M with 100 µg/ml Phytohustil R or 100 µg/ml REAo and additional incubation with 12.5 mM H 2 O 2 significantly (p < 0.01) inhibited the ROS production by 52.4% or by 58.7%. compared to M stimulated with 12.5 mM H 2 O 2 alone (Figure 5) . Figure 6A) . Incubation of M with LPS (0.01 µg/ml) induced a significantly (p < 0.001) increased TNFα release of 87.8% compared to untreated control (Figures 6A,  7A) . Furthermore, M were pre-treated (48 h) with Phytohustil R (50-500 µg/ml), its excipients or REAo and additionally activated with LPS (0.01 µg/ml; 3 h) to measure TNF-α release. Pre-treatment with Phytohustil R significantly inhibited LPS-induced TNF-α release by 21.6% (50 µg/ml, p < 0.01), 34.8% (100 µg/ml, 0.001), 47.3% (200 µg/ml, p < 0.001), 45.2% (400 µg/ml, p < 0.001), and 52.4% (500 µg/ml, p < 0.001) in comparison with LPS-treated M (Figure 7A) . Pre-treatment with REAo significantly inhibited the TNFα release by 18.8% (100 µg/ml, 0.05), 18.3% (200 µg/ml, p < 0.05), 21.5% (400 µg/ml, p < 0.01), and 23.3% (500 µg/ml, p < 0.01) in comparison with LPS-treated M (Figure 7A) . In general, the comparison of the anti-inflammatory effect of different concentrations of Phytohustil R and corresponding concentrations of REAo revealed significantly higher inhibitory effects on the LPS-induced TNF-α release by Phytohustil R by 16.1% (p < 0.05; 100 µg/ml), 28.9% (p < 0.001; 200 µg/ml), 23.7% (p < 0.01; 400 µg/ml), and 29.1% (p < 0.01; 500 µg/ml) (Figure 7A) . Incubation of M with different concentrations of excipients did not inhibit the LPS-induced TNF-α release and was significantly (p < 0.001) higher than the untreated control (Figure 7A) .
Protective Effects of Phytohustil R or REAo on LPS-Induced IL6 Release by M
In order to confirm the anti-inflammatory effects observed by Phytohustil R and REAo we determined the inhibition of the IL6 release of LPS-activated M . Treatment of M with REAo or Phytohustil R (50, 100, 200 , 400, or 500 µg/ml) alone did not affect the IL6 release compared to untreated control ( Figure 6B) . In contrast, treatment with Phytohustil R 's excipients significantly (p < 0.001) induced the release of IL6 compared to untreated control (Figure 6B) . Incubation of M with LPS (1 µg/ml, 3 h) induced a significantly (p < 0.001) increased IL6 release of 86.3% compared to untreated control (Figures 6B,  7B) . Pre-treatment with Phytohustil R significantly inhibited LPSinduced IL6 release by 51.2% (50 µg/ml, p < 0.001), 69.0% (100 µg/ml, p < 0.001), 78.5% (200 µg/ml, p < 0.001), 63.3% (400 µg/ml, p < 0.001), 67.7% (500 µg/ml, p < 0.001) in comparison to LPS-treated M (Figure 7B) . Pre-treatment with REAo significantly inhibited the IL6 release by 24.6% (100 µg/ml, p < 0.05), 34.7% (200 µg/ml, p < 0.05), 49.3% (400 µg/ml, p < 0.001), and 56.46% (500 µg/ml, p < 0.001) in comparison with LPS treated M (Figure 7B) . In general, the comparison of the anti-inflammatory effect of different concentrations of Phytohustil R and corresponding concentrations of REAo revealed significantly higher inhibitory effects on the LPS-induced IL6 release by Phytohustil R 38.5% (p < 0.05, 50 µg/ml) and 44.5% (p < 0.001; 100 µg/ml) and 43.7% (p < 0.01; 200 µg/ml) but not by 400 µg/ml or 500 µg/ml (Figure 7B) .
Incubation of M with excipients corresponding to 100 µg/ml, 200 µg/ml, 400 µg/ml, or 500 µg/ml of Phytohustil R significantly inhibited the IL6 release by 39.9% (p < 0.01), 45.0% (p < 0.001), 34.2% (p < 0.05), or 33.1% (p < 0.05) in comparison with LPS treated M (Figure 7B) .
Comparison of Anti-inflammatory Properties of Phytohustil R or REAo With Diclofenac
The treatment with 0.1 µg/ml LPS (3 h) induced a significant 85.0% (p < 0.001) increase of the TNF-α release compared to the untreated control (Figure 8A) . Pre-treatment with 200 µg/ml diclofenac significantly inhibited LPS-induced TNF-α release by 24.6% (p < 0.01) compared to LPS. Pre-treatment with 200 µg/ml Phytohustil R as well as REAo showed an inhibition of 31.1% (p < 0.01) and 17.8% (p < 0.01) compared to LPS. Whereas Phytohustil R excipients did not inhibit the LPSinduced TNF-α release when compared to LPS (Figure 8A) . Our results also indicate that treatment with 200 µg/ml Phytohustil R was significantly (p < 0.05) 6.7% more effective than 200 µg/ml diclofenac, whereas TNF-α release of REAo was similar to diclofenac (Figure 8A) . Neither diclofenac nor Phytohustil R , its excipients or REAo alone did induce TNF-α release (Figure 8A) . Treatment (3 h) with 1.0 µg/ml LPS resulted in a significant 89.0% (p < 0.001) increase of the IL6 release compared to the untreated control (Figure 8B) . Pre-treatment with 200 µg/ml diclofenac significantly (p < 0.001) inhibited the LPS-induced IL6 release by 83.6%. Pre-treatment with 200 µg/ml Phytohustil R revealed similar anti-inflammatory effects like 200 µg/ml diclofenac (Figure 8B) . Pre-treatment with 200 µg/ml REAo or excipients significantly inhibited LPSinduced IL-6 release. However, this inhibition was significantly lower than 200 µg/ml Phytohustil R or diclofenac (Figure 8B) . At 200 µg/ml neither diclofenac nor Phytohustil R or REAo alone induced an IL6 release. However, incubation with 200 µg/ml excipients alone significantly 26.6% (p < 0.05) induced an IL6 release (Figure 8B) .
Stimulatory Effects of Phytohustil R or REAo on the Migratory Capacity of M
We investigated the migratory capacity of M after treatment with REAo, Phytohustil R or its excipients (300, 400, or 500 µg/ml) using the scratch assay. The results indicate that the treatment with Phytohustil R significantly stimulated the migratory capacity and scratch closure after 24 h treatment in a concentration-dependent manner by 2.0-fold (300 µg/ml, p < 0.05), 2.8-fold (400 µg/ml, p < 0.001), 3.0-fold (500 µg/ml, p < 0.001) compared to untreated control (Figures 9A,B) .
Treatment with 300 µg/ml, 400 µg/ml or 500 µg/ml REAo significantly stimulated the migratory capacity by 2.6-fold (p < 0.01), 2.9-fold (p < 0.001) or 3.2-fold compared to untreated control (Figures 9A,B) . In contrast, the treatment with excipients did not stimulate the migratory capacity (Figures 9A,B) .
DISCUSSION
The discovery of active natural products is of great interest for treatment of disease as dry cough due to irritation of the oral and pharyngeal mucosa. Marshmallow is well-known for its healing properties since ancient time. It has been reported that a water extract from roots of A. officinalis had stimulating effects on cell viability and proliferation of epithelial cells, but not on primary fibroblasts (Deters et al., 2010; Benbassat et al., 2014) . We now found that Phytohustil R increased the viability of M , key components of the innate immune defense system, without revealing cytotoxic effects. In line with these findings, the REAo had positive effects on the viability of epithelial cells involved in the mucosal barrier (Deters et al., 2010) . The regulation of the bioenergetic metabolism plays a central role in the physiology of M , including mitochondria, which play an essential role in regulating the responses of M to injury, pathogens, and inflammation in the tissues (Ravi et al., 2014) . The mitochondrial pathway of apoptosis is mediated by disruption of the outer membrane and consequently the depolarization of the MMP (Gupta et al., 2009 ). Furthermore, MMP impacts directly the control of redox status, proliferation and cell death (Zorov et al., 2014) . Normally, cells maintain stable levels of intracellular ATP and the MMP; this stability is a requisite for normal cell functioning (Zorov et al., 2014) , a disruption of this homeostasis causes cell damage. We found, that treatment of M with different concentrations of Phytohustil R , its excipients or REAo protect the MMP at levels of the untreated control. MMP is implicated in the role of mitochondria in cellular homeostasis, together with ROS generation (Zorov et al., 2014) . ROS include a number of reactive molecules and free radicals derived from molecular oxidation, produced as byproducts during the mitochondrial aerobic respiration and has the potential to cause intracellular damage. Phagocytic cells like M are also responsible for ROS production and play a major role in the activation of cell signaling cascades, including apoptosis (Gupta et al., 2009; Zorov et al., 2014) . We performed experiments to investigate the possible protective properties of Phytohustil R or REAo, against H 2 O 2 -induced cytotoxicity and intracellular ROS production. We found an inhibition of H 2 O 2 -mediated decrease of the viability, when M were pre-treated with Phytohustil R . Our findings are congruent with publications of others (Sadighara et al., 2012; Benbassat et al., 2014) showing that Phytohustil R and REAo have antioxidant properties, stimulate anti-oxidative defense mechanisms and, thus, may protect against intracellular ROS increase, i.e., oxidative stress in M . In contrast to non-mucosal tissues, the mucosal tissues have close contact with numerous and diverse commensal microorganisms, as well as pathogens, which can trigger pro-inflammatory responses. Therefore, inhibition of cytokine production is the common mechanism of action of anti-inflammatory compounds. Topical application of the REAo was shown to act antiinflammatorily to UV-irradiated skin of rabbits (Beaune and Balea, 1966) . Other in vivo experiments indicated a marginal immune-activating effect of extracts or purified marshmallow polysaccharides (Wagner, 1990) . However, an ethanolic extract from marshmallow root, administrated orally, did not inhibit carrageenan-induced rat paw oedema (Mascolo et al., 1987) . In differentiated M , LPS induced a strong dose-dependent upregulation of inflammatory cytokines, such as TNF-α and IL6 (Kato et al., 2004; Chen and Cheng, 2009) , which can be taken as an in vitro test -similar to our M -to investigate antiinflammatory properties of drugs. We found that Phytohustil R and the REAo, but not its excipients, inhibited the LPS-stimulated release of TNF-α and IL6 by M , corroborating the antiinflammatory and possible immunomodulatory properties of the REAo as described by others in neutrophils and monocytes (Scheffer and König, 1991) . In general, cytokines produced by monocytes and M (e.g., TNF-α, IL6) promote monocyte survival and differentiation, and thus, may explain the presence of large number of M in a lesion (Mangan et al., 1993) . We have performed our in vitro experiments using differentiated M instead immature monocytes, because it is well-known that LPS-activated M exhibit another response after pretreatment with anti-inflammatory substances than monocytes (Mangan et al., 1993; Bonaterra et al., 2010) . The results of our experiments showed that pre-treatment with Phytohustil R or REAo inhibit the LPS-induced TNF-α-and IL6 release and corroborate the anti-inflammatory properties of REAo. These anti-inflammatory effects of the REAo and the commercially available product Phytohustil R on differentiated M are shown here for the first time.
The effect of incubation of M with 200 µg/ml Phytohustil R or REAo on LPS-induced TNF-α release was similar to the effects of diclofenac, which served as reference substance. The inhibitory effects of 200 µg/ml Phytohustil R on the IL6 release were comparable to the effect of 100 or 200 µg/ml diclofenac, but not to those of Phytohustil R 'exipients or REAo. Consequently, properties of Phytohustil R and the REAo may have special impact on the resolution of the mucosal inflammation and alleviate the irritated oral and pharyngeal mucosa, which can explain its known pharmacological effects and clinical efficacy.
Monocyte migration plays an important role in physiological and pathological processes that include wound healing, repairing mucosal damage and resolution of inflammation (Leoni et al., 2015) . During the infection process, e.g., after mucosal injury, monocytes are initially recruited from the blood stream into the mucosal injury/wound site (Chanput et al., 2010; Wynn et al., 2013; Crane et al., 2014) and rapidly differentiate into so-called "wound-associated M " (Chanput et al., 2010; Wynn et al., 2013; Crane et al., 2014) . Human THP-1 cells, have widely been used as a model to study the immune response capacity of monocytes and M , because of similarities in their responses, when compared to monocytes isolated from peripheral blood mononuclear cells. Upon differentiation, M lose their proliferative abilities and enhance their antibacterial properties, allowing them to participate in the inflammatory and immune responses (Takashiba et al., 1999) . By using a scratch assay, we showed for the first time that Phytohustil R , and its active ingredient, REAo, concentration-dependently activate the migration of M . Thus, these properties may be associated with an intramucosal chemoattractant activity of Phytohustil R and, the REAo to induce migration of monocyte/M into the injured and inflamed mucosa and may have special effects on the resolution of the inflammation and wound healing (Takashiba et al., 1999; Chanput et al., 2010) . These results are suggested as evidence for a positive repair effect against mucosal injury. Chemotaxis of phagocytes to inflammatory site following a release of several cytokine and chemokine is the first step that is decisive for the activation of the host defense (Hsu et al., 2003) . Pectic polysaccharides were shown to exhibit potent dose-dependent complement fixating activities, and to induce chemotaxis of M , T-lymphocytes and natural killer cells (Inngjerdingen et al., 2005) , a similar mechanism that may explain our results related to the migratory activation of M after treatment with Phytohustil R or the REAo. However, to confirm our in vitro data, additional in vivo experiments are necessary in the future. Finally, it would be highly interesting to investigate, whether Phytohustil R or the REAo do also reveal anti-inflammatory and anti-oxidative effects on epidermal cells (keratinocytes) in vitro.
